InvestorsHub Logo

Hoskuld

11/19/23 11:45 AM

#439274 RE: kevindenver #439272

And those metrics are company specific, too, of course: the multiple on a fast grower like Anavex might be would be far higher than on a slow-growing behemoth like Pfizer.